# Addressing a Common Misconception of Simple Additive and Cumulative Drug Inhibition: Multiple Weak Inhibitors of Common Metabolic Pathway Do Not Pose a Strong Interaction Risk!

**Authors:** Daniel Scotcher, Avijit Ghosh, Aleksandra Galetin, Amin Rostami‐Hodjegan

PMC · DOI: 10.1002/jcph.70154 · 2026-01-30

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12859390/full.md

---
Source: https://tomesphere.com/paper/PMC12859390